Infeksi, Rekomendasi Terapi, dan Resistensi Gonore
DOI:
https://doi.org/10.55175/cdk.v46i8.424Keywords:
Gonore, rekomendasi terapi, resistensi antibiotikAbstract
Gonore (GO) merupakan penyakit infeksi menular seksual (IMS) yang paling sering terjadi, disebabkan oleh Neisseria gonorrhoeae (NG). Di Indonesia, infeksi GO menempati urutan tertinggi penyakit IMS. Pada laki-laki, GO akan menimbulkan uretritis dan pada perempuan biasanya asimptomatik. Infeksi juga dapat terjadi di rektum dan orofaring. Pemeriksaan penunjang dapat menggunakan pewarnaan Gram, kultur, dan nucleic acid amplification test. Dalam dekade terakhir, NG mampu mengembangkan resistensi terhadap antibiotik yang direkomendasikan. Beberapa antibiotik yang dilaporkan telah resisten adalah penisilin, tetrasiklin, kuinolon, seftriakson, sefiksim, dan azitromisin.
Gonorrhea (GO) is one of the most common sexual transmitted diseases (STI), caused by Neisseria gonorrhoeae (NG). In Indonesia, GO infection is the most frequent STI diseases. The infection will cause urethritis in men and usually asymptomatic in women. Infection can also occur in rectum and oropharynx. Test for diagnosis are Gram staining, culture, and nucleic acid amplification test. In the last decade, NG demonstrated the ability to develop antibiotic resistance. Some resistant antibiotics are penicillin, tetracycline, quinolone, ceftriaxone, cefixime, and azithromycin.
Downloads
References
Daili SF, Nilasari H. Infeksi menular seksual. 5th ed. Jakarta: Badan Penerbit FKUI; 2017.
Taylor SN, Morris DH, Avery AK, Workowski KA, Batteiger BE, Tiffany CA, et al. Gepotidacin for the treatment of uncomplicated urogenital gonorrhea: A phase 2, randomized, dose-ranging, single-oral dose evaluation. CID. 2018;67:504-11.
Tshokey T, Tshering T, Pradhan AR, Adhikari D, Sharma R, Gurung K, et al. Antibiotik resistance in Neisseria gonorrhea and treatment outcomes of gonococcalurethritis suspected patients in two large hospitals in Bhutan, 2015. PLoS One [Internet]. 2018; 12(8). Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0201721
WHO. WHO guidelines for the treatment of Neisseria gonorrhoeae. Geneva: WHO; 2016.
Firdiana SE, Muslimin, Farida H. Perbandingan efektifitas seftriakson dengan siprofloksasin pada kuman Neisseria gonorrhoeae secara in vitro. JKD. 2016;5(4):1736-42.
Hananta IPY, Van Dam AP, Bruisten SM, Schim van der Loeff MF, Soebono H, de Vries HJ. Gonorrhea in Indonesia high prevalence of asymptomatic urogenital gonorrhea but no circulating extended spectrum cephalosporins-resistant Neisseria gonorrhoeae strains in Jakarta, Yogyakarta, Denpasar, Indonesia. Sexually Transmitted Diseases. 2016;43(10): 608-16.
Direktorat Jendral Pengendalian Penyakit dan Penyehatan Lingkungan – Kementrian Kesehatan Republik Indonesia. Laporan STBP 2013. Jakarta: Kemenkes RI; 2013.
Menaldi SLSW, Bramono K, Indriatmi W. Ilmu penyakit kulit dan kelamin. 7th ed. Jakarta: Badan Penerbit FKUI; 2016.
Kementrian Kesehatan Republik Indonesia. Pedoman Nasional penanganan infeksi menular seksual 2015. Jakarta: Kemenkes RI; 2015.
Holmes KK, Sparling PF, Stamm WE, Piot P, Wasserheit JN, Corey L, et al. Sexually transmitted diseases. 4th ed. USA: McGraw Hill Medical; 2008.
CDC. Sexually transmitted diseases treatment guidelines 2015. CDC MMWR. 2015;64(3):1-137.
Vincent LR, Jerse AE. Biological feasibility and importance of a gonorrhoea vaccine for global public health. E-J.vaccine [Internet]. 2018. Available from https://www.ncbi.nlm.nih.gov/pubmed/?term=Biological+feasibility+and+importance+of+a+gonorrhea+vaccine+for+global+public+health
WHO. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. Geneva: WHO; 2012.
ASHA. Australian STI management guidelines for use in primary care [Internet]. 2018 [cited 2019 March 11]. Available from: http://www.sti.guidelines.org.au/sexually-transmissible-infections/gonorrhoea#special-treatment-situations
IUSTI. STI treatment pocket european guidelines summary 2018 [Internet]. 2019 [cited 2019 March 24]. Available from: http://iusti.org/regions/Europe/euroguidelines.htm
Dillon JAR, Parti RP, Thakur SD. Antibiotic resistance in Neisseria gonorrhoeae will infections be untreatable in the future. Culture. 2015;35(1):1-7.
Cole MJ, Spiteri G, Town K, Unemo M, Hoffmann S, Chisholm SA, et al. Risk factors for antimicrobial-resistant Neisseria gonorrhoeae in Europa. Sex Transm Dis. 2014; 41(12): 723-9.
Bala M. Antimicrobial resistance in Neisseria gonorrhoeae in South-East Asia. Regional Health Forum. 2011;15(1): 63-70
Setyaningrum T, Astindari, Lumintang H. Uji difusi terhadap Neisseria gonorrhoeae dari wanita pekerja seks (WPS) dengan servisitis gonore tanpa komplikasi yang mengikuti program periodic presumptive treatment (PPT). Berkala Ilmu Kesehatan Kulit dan Kelamin. 2017;29(1):65-72
Stoltey JE, Barry PM. The use of cepalosporins for gonorrhoea: An update on the rising problem of resisitance. Expert Opin. Pharmacother. 2012;13(10):1411-20
Lefebre B, Martin I, Demczuk W, Deshaies L, Michaud S, Labbe AC, et al. Ceftriaxone-resistant Neisseria gonorrhoeae, Canada, 2017. EID. 2018; 24:381-3.
Chen SC, Yin YP, Chen XS. Cephalosporin resistant Neisseria gonorrhoeae clone, China. EID. 2018;24:805,805.
Golparian D, Fernandes P, Ohnishi M, Jensen JS, Unemo M. In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference including those with various high-level antimicrobial resistance – potential treatment option for gonorrhea. AAC. 2012; 56(5):2739-42
Shimuta K, Unemo M, Nakayama S, Morita-Ishihara T, Dorin M, Kawahata T, et al. Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolats in Kyoto and Osaka, Japan, 2010 to 2012: Intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance. AAC. 2013;57(11): 5225-32
Unemo M, Golparian D, Hellmark B. First three Neisseria gonorrhoeae isolats with high-level resistance to azithromycin in Sweden: A threat to currently available dual antimicrobial regimens for treatment of gonorrhoea. AAC. 2014;58:624-5
Mann LM, Kirkcaldy RD, Papp JR, Torrone EA. Susceptibility of Neisseria gonorrhoeae to gentamicin—gonococcal isolate surveillance project, 2015–2016. Sex Transm Dis. 2018; 45(2):96-8
Ardiyanti AR, Sugianto R, Dewi PK, Muslimin. Uji beda sensitivitas kanamisin dengan seftriakson pada kuman Neisseria gonorrhoeae secara in vitro. MMM. 2015;4(4):531-8
Fifer H, Natarajan U, Jones L, Alexander S, Hughes G, Golparian D, et al. Failure of dual antimicrobial therapy in treatment of gonorrhea. N Engl J Med. 2016; 374(25):2504-6
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 https://creativecommons.org/licenses/by-nc/4.0/
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
